Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Prognostic Value of T Cell Receptor Diversity and CD4 Lymphopenia in First Relapse Breast or Lung Cancer Patients

NCT01306188 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT01306188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01306188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Prognostic Value of T Cell Receptor Diversity and CD4 Lymphopenia in First Relapse Breast or Lung Cancer Patients
Lead sponsor
Centre Leon Berard
Phase
Observational
Overall status
Completed
Start date
July 31, 2010
Completion date
December 31, 2014
Enrollment
179 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lung cancer